top of page

ROZLYTREK HARD CAPSULE 200MG

Product details

Registration number: SIN16087P

Classification: Prescription Only

Active ingredients: Entrectinib (Form A) or (Form C)

Strength: 200.00mg

Dosage form: CAPSULE

Route: ORAL

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: L01XE56

HSA approval date: 27 January 2021

Manufacturer(s):

  • Catalent Greenville, Inc.
  • F. Hoffmann-La Roche Ltd (Primary and secondary packaging)
  • Recipharm Leganés S.L.U.

Manufacturing country/countries: UNITED STATES; SWITZERLAND; SPAIN

What are the HSA registration number and classification for ROZLYTREK HARD CAPSULE 200MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16087P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ROZLYTREK HARD CAPSULE 200MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Entrectinib (Form A) or (Form C)

Strength: 200.00mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ROZLYTREK HARD CAPSULE 200MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for ROZLYTREK HARD CAPSULE 200MG?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ROZLYTREK HARD CAPSULE 200MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Catalent Greenville, Inc.
  • F. Hoffmann-La Roche Ltd (Primary and secondary packaging)
  • Recipharm Leganés S.L.U.

Manufacturing country/countries: UNITED STATES; SWITZERLAND; SPAIN

Source for this answer

Where can I look up ROZLYTREK HARD CAPSULE 200MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16087P or the exact product name ROZLYTREK HARD CAPSULE 200MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ROZLYTREK HARD CAPSULE 200MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ROZLYTREK HARD CAPSULE 200MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16087P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page